162 related articles for article (PubMed ID: 8776593)
1. Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors.
Hatada I; Inazawa J; Abe T; Nakayama M; Kaneko Y; Jinno Y; Niikawa N; Ohashi H; Fukushima Y; Iida K; Yutani C; Takahashi S; Chiba Y; Ohishi S; Mukai T
Hum Mol Genet; 1996 Jun; 5(6):783-8. PubMed ID: 8776593
[TBL] [Abstract][Full Text] [Related]
2. Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse.
Hatada I; Mukai T
Nat Genet; 1995 Oct; 11(2):204-6. PubMed ID: 7550351
[TBL] [Abstract][Full Text] [Related]
3. An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.
Hatada I; Ohashi H; Fukushima Y; Kaneko Y; Inoue M; Komoto Y; Okada A; Ohishi S; Nabetani A; Morisaki H; Nakayama M; Niikawa N; Mukai T
Nat Genet; 1996 Oct; 14(2):171-3. PubMed ID: 8841187
[TBL] [Abstract][Full Text] [Related]
4. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
5. Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.
Matsuoka S; Thompson JS; Edwards MC; Bartletta JM; Grundy P; Kalikin LM; Harper JW; Elledge SJ; Feinberg AP
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):3026-30. PubMed ID: 8610162
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of the cyclin-dependent kinase inhibitor gene p57KIP2 in Wilms' tumor.
Thompson JS; Reese KJ; DeBaun MR; Perlman EJ; Feinberg AP
Cancer Res; 1996 Dec; 56(24):5723-7. PubMed ID: 8971182
[TBL] [Abstract][Full Text] [Related]
7. Coding mutations in p57KIP2 are present in some cases of Beckwith-Wiedemann syndrome but are rare or absent in Wilms tumors.
O'Keefe D; Dao D; Zhao L; Sanderson R; Warburton D; Weiss L; Anyane-Yeboa K; Tycko B
Am J Hum Genet; 1997 Aug; 61(2):295-303. PubMed ID: 9311733
[TBL] [Abstract][Full Text] [Related]
8. Selective maternal-allele loss in human lung cancers of the maternally expressed p57KIP2 gene at 11p15.5.
Kondo M; Matsuoka S; Uchida K; Osada H; Nagatake M; Takagi K; Harper JW; Takahashi T; Elledge SJ; Takahashi T
Oncogene; 1996 Mar; 12(6):1365-8. PubMed ID: 8649840
[TBL] [Abstract][Full Text] [Related]
9. A novel human homologue of yeast nucleosome assembly protein, 65 kb centromeric to the p57KIP2 gene, is biallelically expressed in fetal and adult tissues.
Hu RJ; Lee MP; Johnson LA; Feinberg AP
Hum Mol Genet; 1996 Nov; 5(11):1743-8. PubMed ID: 8923002
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase inhibitor p57KIP2 in soft tissue sarcomas and Wilms'tumors.
Orlow I; Iavarone A; Crider-Miller SJ; Bonilla F; Latres E; Lee MH; Gerald WL; Massagué J; Weissman BE; Cordón-Cardó C
Cancer Res; 1996 Mar; 56(6):1219-21. PubMed ID: 8640801
[TBL] [Abstract][Full Text] [Related]
11. Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome.
Lee MP; DeBaun M; Randhawa G; Reichard BA; Elledge SJ; Feinberg AP
Am J Hum Genet; 1997 Aug; 61(2):304-9. PubMed ID: 9311734
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 11p15.5 regional imprinting: comparative analysis of KIP2 and H19 in human tissues and Wilms' tumors.
Chung WY; Yuan L; Feng L; Hensle T; Tycko B
Hum Mol Genet; 1996 Aug; 5(8):1101-8. PubMed ID: 8842727
[TBL] [Abstract][Full Text] [Related]
13. p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
Matsuoka S; Edwards MC; Bai C; Parker S; Zhang P; Baldini A; Harper JW; Elledge SJ
Genes Dev; 1995 Mar; 9(6):650-62. PubMed ID: 7729684
[TBL] [Abstract][Full Text] [Related]
14. Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour.
Taniguchi T; Okamoto K; Reeve AE
Oncogene; 1997 Mar; 14(10):1201-6. PubMed ID: 9121769
[TBL] [Abstract][Full Text] [Related]
15. Genomic organization of the human p57KIP2 gene and its analysis in the G401 Wilms' tumor assay.
Reid LH; Crider-Miller SJ; West A; Lee MH; Massagué J; Weissman BE
Cancer Res; 1996 Mar; 56(6):1214-8. PubMed ID: 8640800
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of the p57KIP2 gene mutation in Beckwith-Wiedemann syndrome.
Bhuiyan ZA; Yatsuki H; Sasaguri T; Joh K; Soejima H; Zhu X; Hatada I; Morisaki H; Morisaki T; Mukai T
Hum Genet; 1999 Mar; 104(3):205-10. PubMed ID: 10323243
[TBL] [Abstract][Full Text] [Related]
17. Loss of imprinting and genetic alterations of the cyclin-dependent kinase inhibitor p57KIP2 gene in head and neck squamous cell carcinoma.
Lai S; Goepfert H; Gillenwater AM; Luna MA; El-Naggar AK
Clin Cancer Res; 2000 Aug; 6(8):3172-6. PubMed ID: 10955800
[TBL] [Abstract][Full Text] [Related]
18. Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation.
Lam WW; Hatada I; Ohishi S; Mukai T; Joyce JA; Cole TR; Donnai D; Reik W; Schofield PN; Maher ER
J Med Genet; 1999 Jul; 36(7):518-23. PubMed ID: 10424811
[TBL] [Abstract][Full Text] [Related]
19. High expression of cyclin E and G1 CDK and loss of function of p57KIP2 are involved in proliferation of malignant sporadic adrenocortical tumors.
Bourcigaux N; Gaston V; Logié A; Bertagna X; Le Bouc Y; Gicquel C
J Clin Endocrinol Metab; 2000 Jan; 85(1):322-30. PubMed ID: 10634406
[TBL] [Abstract][Full Text] [Related]
20. Microdeletion of target sites for insulator protein CTCF in a chromosome 11p15 imprinting center in Beckwith-Wiedemann syndrome and Wilms' tumor.
Prawitt D; Enklaar T; Gärtner-Rupprecht B; Spangenberg C; Oswald M; Lausch E; Schmidtke P; Reutzel D; Fees S; Lucito R; Korzon M; Brozek I; Limon J; Housman DE; Pelletier J; Zabel B
Proc Natl Acad Sci U S A; 2005 Mar; 102(11):4085-90. PubMed ID: 15743916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
